This definition appears very rarely
and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other meanings of LRTI
We have 5 other definitions for LRTI
in our Acronym Attic
Samples in periodicals archive:
Patients not at increased risk of complications whose illness is not severe do not routinely require antiviral treatment; however, those who have symptoms of lower respiratory tract illness, dyspnea, hypoxemia, tachypnea, or other warning symptoms of severe illness should be treated promptly with antivirals.
Role of respiratory viruses in upper and lower respiratory tract illness in the first year of life.
Symptoms that require investigation on country level *AaClusters of cases of unexplained ILI or acute lower respiratory disease *AaSevere, unexplained respiratory illness occurring in one or more health care worker(s) who provide care for patients with respiratory disease *AaChanges in the epidemiology of mortality associated with the occurrence of ILI or lower respiratory tract illness, an increase in deaths observed from respiratory illness or an increase in the occurrence of severe respiratory disease in previously healthy adults or adolescents *AaPersistent changes noted in the treatment response or outcome of severe lower respiratory illness.
Most patients hospitalized with RSV are infants less than one year of age who were admitted with symptoms of lower respiratory tract illness.
Clearly, further studies using larger sample populations, expanded respiratory pathogen detection methods, and control groups are needed to elucidate what role, if any, MCPyV plays in upper and lower respiratory tract illness.
HMPV was first described in a population of children in the Netherlands in 2001 (1) and has subsequently been linked with lower respiratory tract illness (LRTI) in children and adults (2,4).
Lower respiratory tract illness in the first two years of life: epidemiologic patterns and costs in a suburban pediatric practice.
To date, Synagis has successfully helped to reduce the incidence of serious lower respiratory tract illness in more than 700,000 high-risk infants.